MDxHealth SA (MDXH)

MDxHealth SA (MDXH) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $63M; returns 1 day -0.4%, 1 week -11.3%, 1 year -95.8%.

MDxHealth SA (MDXH) is a commercial-stage precision diagnostics company that provides advanced molecular diagnostic solutions primarily for urologic conditions, with a strong focus on prostate cancer and advanced urinary tract infection (UTI) detection. The company's revenue is generated from a comprehensive portfolio of tests, which include both tissue-based and liquid-based assays.

Groups MDXH belongs to

• Healthcare
• Precision Medicine
• Health Diagnostics and Imaging
• Oncology
• Commercial Stage
• Biotechnology
• Healthcare Technology
• Life Sciences
• Medical Devices
• Healthcare Services

MDXH financial model: income statement, cash flow and balance sheet